ERBB2 and breast cancer: The most recurrent subtype of breast cancer diagnosed is the hormone receptor (HR) positive (HR +) and human epidermal growth factor receptor 2 (HER2) negative (HER2 −) BC, which accounts for two-thirds of all BC diagnoses [2].